Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period
Pediatr Rheumatol Online J. 2024 Dec 28;22(1):110. doi: 10.1186/s12969-024-01036-5. ABSTRACT BACKGROUND: Aicardi-Goutières Syndrome is a monogenic type 1 interferonopathy with infantile onset, characterized by a …